195 related articles for article (PubMed ID: 25765725)
1. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.
Deutsch NR; Worthmann H; Steixner-Kumar AA; Schuppner R; Grosse GM; Pan H; Gabriel MM; Hasse I; van Gemmeren T; Lichtinghagen R; Ehrenreich H; Weissenborn K
Brain Behav Immun; 2021 Aug; 96():73-79. PubMed ID: 34010714
[TBL] [Abstract][Full Text] [Related]
3. Response to Letter Regarding Article, "Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke".
Castillo-Gomez E; Ehrenreich H
Stroke; 2015 Jul; 46(7):e178. PubMed ID: 26022633
[No Abstract] [Full Text] [Related]
4. Letter by Macrez et al. Regarding Article, "Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke".
Macrez R; Vivien D; Docagne F
Stroke; 2015 Jul; 46(7):e177. PubMed ID: 26022638
[No Abstract] [Full Text] [Related]
5. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
[TBL] [Abstract][Full Text] [Related]
6. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
Castillo-Gomez E; Kästner A; Steiner J; Schneider A; Hettling B; Poggi G; Ostehr K; Uhr M; Asif AR; Matzke M; Schmidt U; Pfander V; Hammer C; Schulz TF; Binder L; Stöcker W; Weber F; Ehrenreich H
Ann Neurol; 2016 Jan; 79(1):144-51. PubMed ID: 26505629
[TBL] [Abstract][Full Text] [Related]
7. Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
Pan H; Steixner-Kumar AA; Seelbach A; Deutsch N; Ronnenberg A; Tapken D; von Ahsen N; Mitjans M; Worthmann H; Trippe R; Klein-Schmidt C; Schopf N; Rentzsch K; Begemann M; Wienands J; Stöcker W; Weissenborn K; Hollmann M; Nave KA; Lühder F; Ehrenreich H
Mol Psychiatry; 2021 Jun; 26(6):2471-2482. PubMed ID: 32089545
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
Ehrenreich H
Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against the
Ehrenreich H
Front Immunol; 2017; 8():181. PubMed ID: 28298911
[TBL] [Abstract][Full Text] [Related]
10. Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).
Sperber PS; Siegerink B; Huo S; Rohmann JL; Piper SK; Prüss H; Heuschmann PU; Endres M; Liman TG
Stroke; 2019 Nov; 50(11):3213-3219. PubMed ID: 31526121
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.
Pan H; Oliveira B; Saher G; Dere E; Tapken D; Mitjans M; Seidel J; Wesolowski J; Wakhloo D; Klein-Schmidt C; Ronnenberg A; Schwabe K; Trippe R; Mätz-Rensing K; Berghoff S; Al-Krinawe Y; Martens H; Begemann M; Stöcker W; Kaup FJ; Mischke R; Boretius S; Nave KA; Krauss JK; Hollmann M; Lühder F; Ehrenreich H
Mol Psychiatry; 2019 Oct; 24(10):1489-1501. PubMed ID: 29426955
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of autoantibodies against brain antigens in health and disease.
Dahm L; Ott C; Steiner J; Stepniak B; Teegen B; Saschenbrecker S; Hammer C; Borowski K; Begemann M; Lemke S; Rentzsch K; Probst C; Martens H; Wienands J; Spalletta G; Weissenborn K; Stöcker W; Ehrenreich H
Ann Neurol; 2014 Jul; 76(1):82-94. PubMed ID: 24853231
[TBL] [Abstract][Full Text] [Related]
13. Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects.
Daguano Gastaldi V; Bh Wilke J; Weidinger CA; Walter C; Barnkothe N; Teegen B; Luessi F; Stöcker W; Lühder F; Begemann M; Zipp F; Nave KA; Ehrenreich H
Brain Behav Immun; 2023 Feb; 108():135-147. PubMed ID: 36323361
[TBL] [Abstract][Full Text] [Related]
14. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size.
Kalev-Zylinska ML; Symes W; Little KC; Sun P; Wen D; Qiao L; Young D; During MJ; Barber PA
Stroke; 2013 Aug; 44(8):2212-9. PubMed ID: 23723305
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
Hammer C; Stepniak B; Schneider A; Papiol S; Tantra M; Begemann M; Sirén AL; Pardo LA; Sperling S; Mohd Jofrry S; Gurvich A; Jensen N; Ostmeier K; Lühder F; Probst C; Martens H; Gillis M; Saher G; Assogna F; Spalletta G; Stöcker W; Schulz TF; Nave KA; Ehrenreich H
Mol Psychiatry; 2014 Oct; 19(10):1143-9. PubMed ID: 23999527
[TBL] [Abstract][Full Text] [Related]
16. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke.
Bang OY; Saver JL; Alger JR; Shah SH; Buck BH; Starkman S; Ovbiagele B; Liebeskind DS;
Stroke; 2009 Feb; 40(2):454-61. PubMed ID: 19038915
[TBL] [Abstract][Full Text] [Related]
17. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice.
Yue W; Caldwell S; Risbrough V; Powell S; Zhou X
PLoS One; 2021; 16(9):e0256972. PubMed ID: 34473764
[TBL] [Abstract][Full Text] [Related]
18. Rodent stroke induced by photochemical occlusion of proximal middle cerebral artery: evolution monitored with MR imaging and histopathology.
Chen F; Suzuki Y; Nagai N; Jin L; Yu J; Wang H; Marchal G; Ni Y
Eur J Radiol; 2007 Jul; 63(1):68-75. PubMed ID: 17337149
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder.
Hammer C; Zerche M; Schneider A; Begemann M; Nave KA; Ehrenreich H
Mol Psychiatry; 2014 Oct; 19(10):1054-6. PubMed ID: 24888362
[No Abstract] [Full Text] [Related]
20. Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion- and perfusion-weighted magnetic resonance imaging study.
Liu Y; Laakso MP; Karonen JO; Vanninen RL; Nuutinen J; Soimakallio S; Aronen HJ
J Cereb Blood Flow Metab; 2002 Nov; 22(11):1336-42. PubMed ID: 12439291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]